Statera Biopharma, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/22 Q3

ended 06/30/22 Q2

ended 03/31/22 Q1

ended 12/31/21 FY 2021

Late annual filing notification for FY 2021

Prospectuses and Registrations Filter

Removal from listing

Registration of successor issuer's securities

Exempt offering of securities

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Chandrasekhar Satishchandran

Saluck Randy S.

Barbarick Steve K

News Filter

Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC